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Previous studies have shown an elevated risk for preterm delivery among early onset cancer survivors. Whether the preterm
delivery starts spontaneously, due to possible uterine damage because of cancer treatment, or is induced due to maternal
conditions is unclear. Our aim was to assess pregnancy related conditions in female cancer survivors possibly underlying the
elevated risk for preterm labor. Nationwide cancer and birth registries were merged to identify 1,753 ﬁrst deliveries of cancer
survivors (diagnosed below 40 years of age) and 5,123 ﬁrst deliveries of matched female comparison subjects between January
1991 and December 2013. Conditional logistic regression models were used to estimate the risk for pregnancy related
conditions adjusting for maternal age, gestational age and smoking. We found an overall increased risk for hospitalization
during pregnancy (OR 1.45, 95% CI 1.25–1.68), intrahepatic cholestasis (OR 2.86, 95% CI 1.09–7.49), fear of childbirth
(OR 2.25, 95% CI 1.31–3.85) and mental disorders and diseases of the nervous system complicating pregnancy and labor
(OR 5.89, 95% CI 2.31–15.00). Among survivors, 129 (7.4%) delivered preterm compared to 268 (5.2%) comparisons subjects
(p = 0.004). We found a statistically signiﬁcant increased risk for preterm delivery among cancer survivors with vaginal
bleeding (OR 1.35, 95% CI 1.07–1.71) and pre-eclampsia (1.35, 95% CI 1.06–1.72) compared to comparison subjects with the
same condition. Health professionals treating these women should be aware of these risks. In general, however, our results
are reassuring when it comes to pregnancies among cancer survivors.
Introduction
Long-term survival rates for most types of childhood cancers
have improved markedly over the past decades. In a recent
study, the 5-year survival rate for Finnish children diagnosed
in 2000–2010 was as high as 81%,1 paralleling European ﬁg-
ures.2 However, anticancer treatments can result in late com-
plications up to decades after treatments. These adverse health
conditions include impaired fertility3 as well as cardiovascular
conditions4 and metabolic syndrome,5 among others.
Studies have shown an elevated risk for preterm
delivery6–13 among cancer survivors. Various explanations for
this elevated risk have been offered. Abdomino-pelvic irradia-
tion and chemotherapy have been identiﬁed as risk factors for
preterm delivery and low birth weight of the fetus.9–11 In these
survivors, the cancer treatment could lead to impaired uterine
growth and reduced blood ﬂow, resulting in uterine ﬁbrosis
and cervical shortening. This, in turn, could lead to premature
contractions and rupture of the amniotic membranes, possibly
resulting in spontaneous preterm delivery.
One alternate hypothesis is that the history of cancer poten-
tially inﬂuences medical decision making placing the survivor
under increased surveillance and lowering the threshold for
medical interventions.14 Yet another explanation could be
maternal pregnancy related conditions, which are known to
necessitate medically induced preterm birth,15 the most
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common ones being pre-eclampsia, gestational diabetes and
placental pathologies. Previous studies have shown that preg-
nancy related hypertension, induction of labor and elective
cesarean sections6,11,16 are more common among survivors.
The aim of our study was to explore pregnancy related
conditions in female cancer survivors (diagnosed with cancer
under the age of 40) possibly underlying the elevated risk for
preterm labor.
Materials and Methods
Each Finnish citizen and permanent resident living in Finland
is given a personal identity number which enables linkage
between different registries and databases. This retrospective,
nationwide registry based study used data derived from the
linkage of three population-based registers.
Registers
The Finnish Cancer Registry (FCR) began registration in 1953
and coverage in this population-based registry is reported to be
as high as 96% for solid tumors and 86% for hematological
malignancies. Of all cancers, 93% were morphologically veri-
ﬁed.17 The registry data include details of primary cancer
including anatomical site, histology, extent of disease, primary
treatment (radiotherapy, chemotherapy and surgery) and time
of diagnosis (month and year). Cancer cases are divided by
tumor behavior at diagnosis into four different categories,
namely benign, in situ carcinomas, semi-malignant and malig-
nant tumors. In our cohort, in situ and basal cell carcinomas
are excluded but we included benign and semi-malignant CNS
tumors, as their treatment is similar to that of malignant brain
tumors. Childhood cancer diagnoses are categorized using the
International Classiﬁcation of Childhood Cancer (ICCC3).18
The Central Population Register (CPR), founded in 1969,
covers all Finnish residents and includes data on residential
history and emigration, as well as possible date of death.
The Medical Birth Register (MBR) contains detailed data
on all mothers giving birth and their children born in Finland
from 1987 onwards. All live births and stillbirths with a birth
weight of more than 500 g or a pregnancy continuing for a
minimum of 22 weeks are recorded in this registry. Data of
less than 0.1% of infants are missing in the MBR.19
Data on pregnancy related conditions requiring hospitali-
zation and the indication for hospitalization have been
recorded in the MBR from October 1990 onwards. Data on
premature rupture of the amniotic membranes, gestational
diabetes, fear of childbirth, mental disorders and diseases of
the nervous system complicating pregnancy and childbirth are
available since January 2004 in the MBR.
Study design
We identiﬁed 25,816 female cancer patients (hereafter referred
to as survivors) diagnosed with a malignant neoplasm or
benign brain tumor up to the age of 40 years between January
1957 and December 2012 from the FCR (Fig. 1). From the
CPR, we sampled ﬁve age-matched female comparison sub-
jects per case (129,080). After excluding comparisons that
were diagnosed with early onset cancer (7,726 women),
121,353 population comparisons remained.
By further linkage to the MBR, we identiﬁed 8,097 survi-
vors and 45,953 comparison subjects with deliveries between
January 1991 and December 2013.
After excluding women whose cancer was diagnosed dur-
ing pregnancy or who had given birth before cancer diagnosis,
3,005 survivors were left.
To eliminate possible inﬂuences of obstetric history on the
endpoint studied, only singleton, ﬁrst deliveries were included,
leaving us with 1,952 survivors. Not all survivors had
matched, female comparison subjects with ﬁrst deliveries,
which is why only 1,753 survivors and their 5,123 matched
comparisons were included in the study (Fig. 1).
The primary, pregnancy related outcomes, analyzed were:
hospital stays exceeding 7 days around delivery and hospitali-
zation during pregnancy (due to any cause and further sub
classiﬁed into threatened preterm labor, unexplained vaginal
bleeding, pre-eclampsia and other reasons than vaginal bleed-
ing, pre-eclampsia or threatened preterm labor). Threatened
preterm labor was deﬁned as hospitalization due to cervical
shortening or premature contractions and pre-eclampsia was
deﬁned as gestational hypertension and/or pre-eclampsia
including essential hypertension diagnosed before pregnancy.
Less severe conditions of threatened preterm labor, vaginal
bleeding, pre-eclampsia and other conditions that did not
require hospitalization were excluded. Gestational diabetes
was deﬁned as a pathological 2-h oral glucose tolerance test
result. ICD-10 diagnostic codes were used to identify the after
conditions from the MBR data: premature rupture of the
membranes (O42.0, O42.1, O42.2 and O42.9), intrahepatic
cholestasis (O26.6) fear of childbirth (O99.80), mental disor-
ders and diseases of the nervous system complicating preg-
nancy and childbirth (O99.3 which include mental and
What’s new?
While previous studies suggest that the risk of preterm delivery is elevated among early-onset cancer survivors, the reasons
underlying the association are unclear. In the present study, female cancer survivors diagnosed under age 40 in Finland were
found to have an increased risk of hospitalization during pregnancy when compared to healthy subjects. Female early-onset
cancer survivors also were at increased risk of fear of childbirth and mental conditions and disorders of the nervous system
that potentially complicated pregnancy and labor. Risk of preterm delivery was further elevated among cancer survivors with
vaginal bleeding and pre-eclampsia during pregnancy.
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behavioral disorders F00-F99 and diseases of the nervous sys-
tem G00-G99 in ICD-10). According to Finnish clinical guide-
lines, pregnant women are asked about their feelings and
attitudes toward childbirth in primary health care. Those who
are particularly fearful are referred to specialist maternity care.
Normal worries and minor fear of childbirth are treated in
primary health care. Finland has introduced a speciﬁc ICD-10
code for fear of childbirth (O99.80), which we utilized to iden-
tify these women.
Statistical analysis
Differences between survivors and comparison subjects in cat-
egorical variables were analyzed using the χ2-test. Conditional
logistic regression analysis was used to estimate odd ratios
(ORs) with 95% conﬁdence intervals (CI) for obstetric compli-
cations categorized as dichotomous variables comparing survi-
vors to the comparison group, adjusting for maternal age at
delivery, gestational age and maternal smoking. The level of
statistical signiﬁcance was set at p < 0.05.
Figure 1. Female cancer survivors and their matched (by gender and age) female comparison group. Criteria for inclusion of deliveries and
number of mothers and offspring included in the ﬁnal analysis.
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To identify possible patient and/or cancer treatment
related risk factors, we performed sub-analyses on all above
mentioned pregnancy related outcomes (except intrahepatic
cholestasis and mental disorders and diseases of the nervous
system which were excluded due to small numbers), stratify-
ing by time from diagnosis to delivery (0–5 years, 6–10 years
and over 10 years), cancer treatment (chemotherapy, radio-
therapy and surgery only) and diagnostic age. Pediatric
patients were deﬁned as survivors treated at the age of
0–14 years, adolescents and young adults at the age of
15–24 years and adults at the age of 25–39 years. In these ana-
lyses, 95% CIs were corrected for multiple comparisons using
the Bonferroni correction. Supplementary analyses were per-
formed by further analyzing survivors treated with abdominal
radiotherapy and abdominal surgery only. In addition, fre-
quencies of pregnancy outcomes according to cancer type
compared to comparison subjects were calculated.
Calendar time was categorized into two time periods
(1991–2002 and 2003–2013), maternal age into four categories
(under 25 years, 25–29 years, 30–34 years and 35 years or
more) and gestational age as less than 32 weeks (early pre-
term), 32–36 weeks (preterm), 37–41 weeks (full term) or
more than 42 weeks (post-term). Information on maternal
smoking was available as smokers, nonsmokers and those with
missing information.
To identify the reasons for preterm delivery we compared
pregnancy related conditions among preterm (less than
37 gestational weeks) and term pregnancies (37–41 gesta-
tional weeks) using conditional logistic regression adjusting
for maternal age at delivery, maternal smoking and early
onset cancer. To study whether survivors with pregnancy
related condition have an excess risk for preterm delivery
compared to corresponding comparison subjects and survi-
vors without pregnancy related condition, we included inter-
actions and tested their signiﬁcance using the likelihood ratio
tests.
We conducted a systematic literature search in PubMed
with combination of the terms “pregnancy outcomes”, “pre-
term”, “delivery”, “cancer” and “survivorship” for studies on
humans and published in English up to April 2018. Inclusion
criteria for studies on pregnancies or deliveries in childhood,
adolescent and young adult and adult female cancer survivors
were carefully examined.
Analyses were conducted using STATA 14.0.
Table 1. Descriptive characteristics of postdiagnosis first pregnancies of female cancer survivors and first pregnancies of a female comparison
group
Characteristics Subcategory Survivors (N = 1,753) N (%) Comparisons (N = 5,123) N (%) p value
Age at delivery <25 331 (18.88) 1,515 (29.57) <0.001
25–29 599 (34.17) 2,111 (41.21)
30–34 552 (31.49) 1,149 (22.43)
35 or more 271 (15.46) 348 (6.79)
Time period of delivery 1991–2002 665 (37.93) 2,585 (50.46) <0.001
2003–2013 1,088 (62.07) 2,538 (49.54)
Maternal smoking No 1,494 (85.23) 4,130 (80.62) 0.056
Yes 227 (12.95) 885 (17.28)
Missing 32 (1.83) 108 (2.11)
Infant sex Male 911 (51.97) 2,643 (51.59) 0.785
Female 842 (48.03) 2,480 (48.41)
Gestational age <32 32 (1.83) 42 (0.82) 0.004
32–36 97 (5.53) 226 (4.41)
37–41 1,513 (86.31) 4,528 (88.39)
42 or more 109 (6.22) 316 (6.17)
Missing 2 (0.11) 11 (0.21)
Birth weight (g) <1,500 31 (1.77) 36 (0.70) 0.002
1,500–2,499 73 (4.16) 163 (3.18)
2,500–3,999 1,421 (81.06) 4,218 (82.33)
4,000–4,499 205 (11.69) 619 (12.08)
4,500 or more 23 (1.31) 87 (1.70)
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Ethics
Our study protocol, including the use of administrative health
data, was approved by the National Institute for Health and
Welfare and Central Population Register (Dnro 918/410/14)
and includes an ethical evaluation of the study (Dnro
THL/1/5.05.00/2014). No identiﬁable personal-level data were
available in the analysis and patients were not contacted.
Results
The descriptive characteristics of survivors and female compari-
son subjects are presented in Table 1. The age at delivery was
slightly higher among survivors than among population com-
parison (mean age 29.7 and 27.6 years respectively, p < 0.001).
Survivors tended to give birth more often during the most recent
time period compared to comparison subjects (p < 0.001).
Both preterm delivery and low birth weight were more
common among survivors than comparisons as 7.4% of can-
cer survivors compared to 5.2% of comparisons delivered pre-
term (p = 0.004 and p = 0.002).
The proportion of preterm deliveries among survivors
remained stable (7.4%) when comparing the earlier time
period of 1991–2002 to the most recent available time period
of 2003–2013.
The patient characteristics of the survivors are listed in
Table 2. In all, 41.6% of the survivors delivered within 6 years
of their cancer diagnosis. The largest diagnostic group con-
sisted of carcinomas and other malignant epithelial neoplasms
(42.2%), followed by lymphomas (18.7%), leukemia (10.3%)
and tumors of the central nervous system (10.3%). In all,
40.6% of cancer patients had received only surgical treatment,
while 31.9% had received radiotherapy and 31.7% had
received chemotherapy according to treatment data from the
ﬁrst 4 months after diagnosis recorded in the FCR. When it
comes to tumor behavior, 5.0% were benign, 2.4% semi-
malignant and 92.6% malignant.
During pregnancy, 394 (22.5%) survivors compared to
906 (17.7%) population comparisons were hospitalized (OR 1.45,
95% CI 1.25–1.68). In most cases hospitalization was due to rea-
sons other than vaginal bleeding, pre-eclampsia or threatened
preterm labor (OR 1.46, 95% CI 1.23–1.73) (Table 3).
When it comes to pregnancy related conditions possibly
leading to medically induced preterm birth, we found that
18 (1.8%) survivors compared to 20 (0.9%) comparisons suf-
fered from intrahepatic cholestasis (OR 2.86, 95% CI 1.09–7.49)
and 42 (4.2%) survivors compared to 46 (2.1%) comparisons
were diagnosed with fear of childbirth (OR 2.25, 95% CI
1.31–3.85). Also mental disorders and diseases of the nervous
system were more common among survivors as 28 (2.8%) survi-
vors and 16 (0.7%) comparison subjects suffered from these
conditions (OR 5.89, 95% CI 2.31–15.00). However, the overall
risk for vaginal bleeding, pre-eclampsia and gestational diabetes
was not increased among survivors compared to comparisons.
It is noteworthy that survivors (49.6%) more often than
comparisons (42.7%) had undergone a 2-h oral glucose toler-
ance test (x2-test, p < 0.001).
In our data, women (both survivors and comparisons) who
delivered preterm more often had hospital stays during preg-
nancy and more often stayed at least 7 days in the hospital
after birth compared to women who delivered full term.
Women delivering preterm also had an increased risk for pre-
Table 2. Diagnostic characteristics of female cancer survivors
experiencing their first postdiagnosis pregnancy
Characteristics Subcategory
Survivors
(N = 1,753) N
(%)
Year of
diagnosis
1957–1972 12 (0.68)
1973–1992 666 (37.99)
1993–2012 1,075
(61.32)
Age at
diagnosis
0–14 398 (22.70)
15–24 770 (43.92)
25–39 585 (33.37)
Time from
diagnosis to
delivery
(years)
0–5 729 (41.59)
6–10 474 (27.04)
11–38 550 (31.37)
Cancer type Leukemia 181 (10.33)
Lymphoma 328 (18.71)
Central Nervous System 181 (10.33)
Sympathetic Nervous System 30 (1.71)
Retinoblastoma 12 (0.68)
Renal Tumors 38 (2.17)
Malignant bone Tumors 35 (2.00)
Soft Tissue and other Sarcomas 72 (3.93)
Germ cell, Gonadal and
Trophoblastic neoplasms
70 (3.99)
Carcinomas and other malignant
epithelial neoplasms
739 (42.16)
Digestive system 120 (6.85)
Breast 80 (4.56)
Melanoma of the skin 183 (10.44)
Thyroid gland 246 (14.03)
Others 110 (6.27)
Others 16 (0.91)
Missing 55 (3.14)
Cancer
treatment
Chemotherapy 556 (31.72)
Radiotherapy 559 (31.89)
Surgery, only 712 (40.62)
Missing 219 (12.49)
1958 Pregnancy-Related Risks in Cancer Survivors
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eclampsia and vaginal bleeding (Adjusted OR for preterm
labor1 in Table 4).
Analyzing the effect that cancer alone had on preterm
delivery (Adjusted OR for early onset cancer2 in Table 4), we
found that survivors did not have an excess risk for preterm
delivery compared to comparison subjects with the same con-
dition in any of the outcomes. However, we identiﬁed a
statistically signiﬁcant increased risk for preterm delivery
among cancer survivors with vaginal bleeding (OR 1.35, 95%
CI 1.07–1.71) and pre-eclampsia (1.35, 95% CI 1.06–1.72)
compared to comparison subjects with the same condition.
Looking at sub-analyses, stratifying by time from cancer
diagnosis to delivery (Supporting Information Table S1), sur-
vivors delivering within 6 years of cancer treatment had the
Table 3. Adjusted odd ratios (ORs) for pregnancy outcomes between 1991 and 2013 among female cancer survivors with their first
postdiagnosis pregnancy compared to first pregnancies in a matched female comparison group
Pregnancy outcome
Survivors
(N = 1,753) (%)
Comparisons
(N = 5,123) (%)
Adjusted OR1
(95%CI)
Hospital stay >7 days 190 (10.84) 446 (8.71) 1.10 (0.90–1.34)
Any hospitalization 394 (22.48) 906 (17.68) 1.45 (1.25–1.68)
Hospitalization for other reason than vaginal bleeding,
pre-eclampsia or threatened preterm labor
280 (15.97) 617 (12.04) 1.46 (1.23–1.73)
Pregnancy outcomes possibly leading to
spontaneous preterm delivery
Hospitalization for threatened preterm labor 49 (2.80) 105 (2.05) 1.39 (0.91–2.12)
Preterm rupture of the membranes2 41 (4.08) 68 (3.04) 1.21 (0.67–2.17)
Pregnancy outcomes possibly leading to
medically iatrogenic preterm birth
Hospitalization for vaginal bleeding 24 (1.37) 52 (1.02) 1.31 (0.74–2.31)
Hospitalization for pre-eclampsia 97 (5.53) 258 (5.04) 1.11 (0.85–1.45)
Gestational diabetes2 109 (10.85) 196 (8.77) 1.06 (0.78–1.43)
Intrahepatic cholestasis2 18 (1.79) 20 (0.89) 2.86 (1.09–7.49)
Fear of childbirth2 42 (4.18) 46 (2.06) 2.25 (1.31–3.85)
Mental disorders and diseases of the nervous system2 28 (2.79) 16 (0.72) 5.89 (2.31–15.00)
OR, odd ratio; CI, confidence interval. Bold indicates statistically significant odds ratios. p-value < 0.05.
1Adjusted for maternal age, gestational age and maternal smoking.
2Data available from 2004 to 2013 (1,005 survivors and 2,236 female controls).
Table 4. Adjusted odd ratios for pregnancy outcomes between 1991 and 2013 comparing preterm deliveries (gestational age below 37 weeks)
with full-term deliveries as well as adjusted odd ratios for pregnancy outcomes due to early onset cancer
Pregnancy outcome
Preterm
(N = 397) (%)
Full term
(N = 6,466) (%)
Adjusted OR for
preterm labor1
(95%CI)
Adjusted OR for
early onset cancer 2
(95% CI)
Hospital stay >7 days 151 (38.04) 484 (7.49) 9.14 (6.47–12.91) 1.06 (0.77–1.46)
Any hospitalization 161 (40.55) 1,137 (17.58) 3.33 (2.52–4.39) 1.14 (0.84–1.55)
Hospitalization for other reason than
vaginal bleeding, pre-eclampsia
or threatened preterm labor
94 (23.68) 801 (12.39) 2.11 (1.56–2.87) 1.38 (1.06–1.80)
Pregnancy outcomes possibly leading to spontaneous preterm delivery
Hospitalization for threatened preterm labor 47 (11.84) 107 (1.65) 8.48 (4.65–15.47) 1.21 (0.94–1.55)
Preterm rupture of the membranes3 39 (19.70) 70 (2.30) 14.56 (5.32–39.89) 1.25 (0.83–1.89)
Pregnancy outcomes possibly leading to
medically iatrogenic preterm birth
Hospitalization for vaginal bleeding 12 (3.02) 64 (0.99) 5.70 (2.11–15.40) 1.35 (1.07–1.71)
Hospitalization for pre-eclampsia 51 (12.85) 309 (4.72) 3.02 (1.96–4.65) 1.35 (1.06–1.72)
Gestational diabetes2 19 (9.60) 286 (9.41) 0.87 (0.42–1.80) 1.44 (0.98–2.10)
Intrahepatic cholestasis2 4 (2.02) 34 (1.12) 1.92 (0.33–11.10) 1.35 (0.94–1.95)
Fear of childbirth2 1 (0.51) 87 (2.86) 0.18 (0.02–1.45) 1.39 (0.96–2.01)
Mental disorders and diseases of the nervous system2 4 (2.02) 40 (1.32) 1.99 (0.38–10.46) 1.40 (0.97–2.02)
OR, odd ratio; CI, confidence interval. Bold indicates statistically significant odds ratios.
1Adjusted for maternal age, maternal smoking and early onset cancer.
2Adjusted for maternal age and maternal smoking.
3Data available from 2004-2013 (198 preterm and 3,040 full term deliveries)
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highest risk for overall hospitalization (OR 1.75, 95% CI
1.34–2.30) and hospitalization for other reasons than vaginal
bleeding, pre-eclampsia or threatened preterm labor (OR 1.76,
95% CI 1.30–2.39). According to diagnostic age (Supporting
Information Table 2), adolescents and young adults (age
15–25 years) had the highest risk for overall hospitalization
(OR 1.62, 95% CI 1.24–2.10), hospitalization due to vaginal
bleeding (OR 2.83, 95% CI 1.11–7.18) and fear of childbirth
(OR 3.72, 95% CI 1.15–12.02) compared to comparison sub-
jects. Regarding cancer treatments, survivors treated with sur-
gery alone had the highest risk for overall hospitalization
(OR 1.58, 95% CI 1.16–2.14) but the risk was also increased
among survivors treated with chemotherapy and radiation.
Survivors treated with surgery alone was the only treatment
group with increased risk for fear of childbirth (OR 3.67, 95%
CI 1.15–11.74) compared to comparisons (Supporting Infor-
mation Table 3). Supplementary analyses of survivors treated
with abdominal radiotherapy (107 survivors) and abdominal
surgery only (164 survivors) did not show an increased risk
for pregnancy related conditions but the numbers were small.
The risk for threatened preterm labor, preterm rupture of
membranes, pre-eclampsia or gestational diabetes was not
increased in any of the subgroups.
Frequencies of pregnancy outcomes according to the most
common cancer types can be found in Supporting Informa-
tion tables (Supporting Information Tables 4 and 5).
Discussion
We studied different pregnancy related conditions that could
explain the increased risk for preterm delivery observed
among early onset cancer survivors.
In our study, cancer survivors had a signiﬁcantly increased
risk for preterm delivery compared to comparison subjects.
An overall increased risk for hospitalization during pregnancy,
intrahepatic cholestasis, fear of childbirth and mental disor-
ders and diseases of the nervous system complicating preg-
nancy and labor was also observed. We found a statistically
signiﬁcant increased risk for preterm delivery among cancer
survivors with vaginal bleeding and pre-eclampsia compared
to comparison subjects with the same condition.
The main strengths of our study is population-based data
originating from consistent, homogenous and reliable national
registers covering a large number of pregnancies over a long
period of time.17–19 Registry based data provided information
on outcomes studied as well as important confounders,
making it possible to adjust for different factors that might
interfere with the outcomes. Registry data are, as opposed to
self-reported data, free of recall and reporting bias because
practically all individuals can be followed for the studied out-
comes. Based on a systematic literature search, our study is
the ﬁrst to explore preterm delivery among cancer survivors
and matched comparison subjects according to different preg-
nancy related conditions.
The main limitation of our study is lack of treatment expo-
sure data. As the outcomes studied, are affected by local dam-
age to the reproductive system, these exposures are particularly
important. Furthermore, data did not contain complete infor-
mation on all reasons for hospitalization during pregnancy
and some diagnostic groups were unspeciﬁc or combined sev-
eral different diseases, mental disorders and diseases of the
nervous system as an example. Information on socioeconomic
status was missing in one third of the study population because
young women are often students or at home taking care of
their children. Instead, we used data on smoking as a proxy
when adjusting for socioeconomic factors, since this has been
found to be a good proxy for socioeconomic status in Fin-
land.20 Subgroup analyses by cancer type resulted in such small
numbers, that reporting risks was not sensible.
As in previous studies,6–13 we found survivors to have a
signiﬁcantly increased risk for preterm delivery compared to
comparison subjects. We also found a 45% higher risk for
overall hospitalization among survivors compared to popula-
tion comparisons but could not identify any speciﬁc reasons
for the increased risk for hospitalization as most survivors
belonged to the category hospitalization for other reasons than
vaginal bleeding, pre-eclampsia or threatened preterm labor.
One recent study found that childhood cancer survivors in
Finland have a relative risk of 1.87 compared to matched con-
trols to be hospitalized for all medical indications in adult
life,21 thus cancer survivors suffer from late morbidities,
namely chronic diseases, after cancer.
An Australian study8 reported an increased risk for pre-
eclampsia (OR 1.44, 95% CI 1.13–1.87), gestational diabetes
(OR 1.38, 95% CI 1.09–2.98) and hospital stays exceeding
5 days (OR 3.01, 95% CI 1.72–5.58) among cancer survivors
compared to women without a history of cancer, which is in
conﬂict with our results. However, the risks for vaginal bleed-
ing during pregnancy, preterm rupture of the amniotic mem-
branes and threatened preterm labor were not increased. our
study covered a large number of ﬁrst completed pregnancies
over a long period of time. As a comparison group they
included women without a history of cancer, giving birth dur-
ing the same period of time and matched on maternal age
group, parity and year of delivery. In our study, only cancer
survivors diagnosed as adolescents, young adults and adults
(15–39 years) were included.
Another recent study22 found that treatment with abdomi-
nal radiotherapy increases the risk of hypertension complicat-
ing pregnancy in Wilms tumor survivors as well as gestational
diabetes and anemia in all survivors. our study covered only
childhood cancer survivors (diagnosed at the age of
0–14 years) and included also multiparous women.
According to our study, survivors had a more than two-
fold increased risk for fear of childbirth, an almost three-fold
increased risk for intrahepatic cholestasis and close to six-fold
increased risk for the combined group of mental disorders
and diseases of the nervous system complicating pregnancy
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and childbirth, which to our knowledge are new ﬁndings. Stud-
ies mostly conducted in the Nordic countries, have found that
6–10% of all pregnant women suffer from severe fear of child-
birth.23,24 Fear of childbirth is often the underlying reason for
the mothers’ request for cesarean section and could, if
untreated, lead to unnecessary cesarean section without medical
indication. Mental health problems are twice as common
among women with fear of childbirth as in nonfearful con-
trols.25 Depression is the most common mental disease among
pregnant women with a prevalence of 10–15% of all pregnant
women.26 According to one study, cancer survivors in the
United States reported medication use for anxiety and depres-
sion at rates nearly two times those reported by the general pub-
lic.27 Anxiety and depression are both factors that have been
associated with an increased risk for both iatrogenic and sponta-
neous preterm delivery.28 Intrahepatic cholestasis is associated
with an increased risk for fetal distress and preterm labor.29
We found a statistically signiﬁcant increased risk for preterm
deliveries among cancer survivors with vaginal bleeding and pre-
eclampsia compared to comparison subjects with the same
condition. Our results suggest that these pregnancy-related con-
ditions, possibly leading to medically induced preterm birth,
tend to be more severe among survivors compared to
comparison subjects. Another possibility is that the history of
cancer inﬂuences decision making, lowering the threshold for
medical intervention in these survivors, leading to preterm
delivery.
Early onset cancer survivors have an increased risk for pre-
term deliveries compared to population comparison subjects.
This could be explained either by certain pregnancy-related
conditions which seem to be more severe among survivors than
comparison subjects, possibly leading to medically induced pre-
term birth or the history of cancer, lowering the threshold for
medical interventions leading to preterm delivery among survi-
vors. Survivors also have an increased risk for hospitalization
during pregnancy, intrahepatic cholestasis, fear of childbirth
and mental disorders and diseases of the nervous system com-
pared to female comparisons. Health professionals treating
these women should be aware of these risks and consider indi-
vidualized follow-up when indicated. In general, however, our
results are reassuring when it comes to pregnancies among can-
cer survivors.
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